SCHEMBL13588386

SCHEMBL13588386

CC1=NNNN1c1ncccc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 2/20 0.56
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 4/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 4/20 0.42
MAPT P10636 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
BLM P54132 1/20 0.42
AGER Q15109 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 3/20 0.41
NAPRT Q6XQN6 2/20 0.41
EGLN1 Q9GZT9 2/20 0.41
GAA P10253 2/20 0.39
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13588385 0.89 MYC (0.42) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL862954 0.77 MYC (0.56) MYCKDM4ETDP1ALDH1A1MAPT
SCHEMBL15714407 0.72 MYC (1.00) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL863139 0.71 MYC (0.42) MYCKDM4ETDP1ALDH1A1MAPT
SCHEMBL3350879 0.70 MYC (0.57) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL16155571 0.68 MYC (0.60) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL27775136 0.68 MYC (0.60) MYCKMT2AKDM4ETDP1ALDH1A1
Hydrochloric Acid SCHEMBL17746081 0.67 MYC (0.58) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL71547 0.67 KDM4E (0.63) MYCKMT2AKDM4ETDP1ALDH1A1
SCHEMBL29651292 0.67 KDM4E (0.63) MYCKMT2AKDM4ETDP1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329721-B2 Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-12-11 US disclosed
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS PFIZER INC. 2009-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298821-A1 HYDROXY AND ALKOXY SUBSTITUTED IH-IMIDAZONAPHTHYRIDINES AND METHODS IL2, IL4, IFNG MYC 165/4885KMT2A 3588/4885KDM4E 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.